Amongst many another stakeholders in the global fight against counterfeit medicines, Atlantic Zeiser presented solutions for one of the key and legislative requirements outlined in the recently published delegated act (EU) 2016/161 to address this serious issue.
Pharmaceutical
Pharma Packaging Conference: Delegated Regulation (EU) 2016/161
The directive (EU) 2016/161 “Falsified Medicines Directive“ has now been published. During the 10th Jahresforum Pharma Packaging in Berlin numerous experts discussed this topic, among them Dr. Stefan Oeing, Director Business Development at Atlantic Zeiser.
PHARM Connect Congress
Atlantic Zeiser on the “PHARM Connect Congress” in Budapest, Hungary. The mission statement of this year’s event was, “If you don’t drive your business, you will be driven out of business”.
Pharmaceutical serialization solutions at Pharmapack
As expected the recently issued delegated act EU 2016/161 was one of the main topics of this year’s show.
Serialization of pharmaceutical products: EU delegated act 2016/161 now published
The realization of the European directive 2011/62/EU („Falsified Medicines Directive“) is now heating up: Today the delegated act was officially published in its final release (EU) 2016/161 in the Journal of the European Union.
